International Science Index


17251

Multifunctional Cell Processing with Plasmonic Nanobubbles

Abstract:

Cell processing techniques for gene and cell therapies use several separate procedures for gene transfer and cell separation or elimination, because no current technology can offer simultaneous multi-functional processing of specific cell sub-sets in heterogeneous cell systems. Using our novel on-demand nonstationary intracellular events instead of permanent materials, plasmonic nanobubbles, generated with a short laser pulse only in target cells, we achieved simultaneous multifunctional cell-specific processing with the rate up to 50 million cells per minute.

References:


[1] G. Tricot, et al. Collection, tumor contamination, and engraftment kinetics of highly purified hematopoietic progenitor cells to support high dose therapy in multiple myeloma, Blood 1998; 91: 4489-4495.
[2] A. Al-Mawali, D. Gillis, I. Lewis, The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia, Am J Clin Pathology 2009; 131:16-26.
[3] S. Rutella, et al. Immune reconstitution after transplantation of autologous peripheral CD34+ cells: analysis of predictive factors and comparison with unselected progenitor transplants, Br J Haematol 2000; 108:105-115.
[4] A. Pfeifer, I.M. Verma, Gene therapy: promises and problems, Annu Rev Genomics Hum Genet 2001; 2:177-211.
[5] T.K. Kim, J.H. Eberwine, Mammalian cell transfection: the present and the future, Anal Bioanal Chem 2010; 397:3173-3178.
[6] M.-L. Rogers, R.A. Rush, Non-viral gene therapy for neurological diseases, with an emphasis on targeted gene delivery, J Controlled Release 2012; 157:183–189.
[7] V. Torchilin, Liposomes in drug delivery, In: Fundamentals and Applications of Controlled Release Drug Delivery, Advances in Delivery Science and Technology, Part 4, 2012; 289-328.
[8] C.X. He, Y. Tabata, J.Q. Gao, Non-viral gene delivery carrier and its three-dimensional transfection system, Int J Pharm 2010; 386:232-242.
[9] F. Scheibe, et al. Nonviral gene delivery of erythropoietin by mesenchymal stromal cells, Gene Ther 2012; 19:550-560.
[10] V.M. Gaspar, et al. Nanoparticle mediated delivery of pure P53 supercoiled plasmid DNA for gene therapy, J Controlled Release 2011;156:212-222.
[11] D. Pissuwan, T. Niidome, M.B. Cortie, The forthcoming applications of gold nanoparticles in drug and gene delivery systems, J Controlled Release 2011; 149:65-71.
[12] M. Bazan-Peregrino, C.D. Arvanitis, B. Rifai, L.W. Seymour, C.-C. Coussios, Ultrasound-induced cavitation enhances the delivery and therapeutic efficacy of an oncolytic virus in an in vitro model, J Controlled Release 2012; 157:235–242.
[13] Y. Choi, et al. A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the specificity of human T cells, Biomed Microdevices 2010; 12:855-863.
[14] J.S. Soughayer, et al. Characterization of cellular optoporation with distance, Anal Chem 2000; 72:1342-1347.
[15] Y. Arita, et al. Spatially optimized gene transfection by laser-induced breakdown of optically trapped nanoparticles, Appl Phys Lett 2011; 98 093702.
[16] D. Stevenson, et al. Femtosecond optical transfection of cells: viability and efficiency, Opt Express 2006; 14:7125-7133.
[17] M. Schomaker, et al. Plasmonic perforation of living cells using ultrashort laser pulses and gold nanoparticles, SPIE Proc 2009; 7192: 71920U.
[18] R. Dijkink, et al. Controlled cavitation-cell interaction: trans-membrane transport and viability studies, Phys Med Biol 2008; 53:375-390.
[19] E. Lukianova-Hleb, et al. Plasmonic nanobubbles as transient vapor nanobubbles generated around plasmonic nanoparticles, ACS Nano 2010; 4:2109-2123.
[20] E. Lukianova-Hleb, et al. Selective gene transfection of individual cells in vitro with plasmonic nanobubbles, J Controlled Release 2011; 152:286-293.
[21] E. Lukianova-Hleb, D. Wagner, M. Brenner, D. Lapotko, Cell-specific transmembrane injection of molecular cargo with gold nanoparticle-generated transient plasmonic nanobubbles, Biomaterials 2012; 33:5441-5450.
[22] E.Y. Lukianova-Hleb, M. Mutonga, D.O. Lapotko, Cell-specific multifunctional processing of heterogeneous cell systems in a single laser pulse treatment, ACS Nano 2012; 6:10973-10981.
[23] E.Y. Lukianova-Hleb, X. Ren, J.A. Zasadzinski, X. Wu, D.O. Lapotko, Plasmonic nanobubbles enhance efficacy and selectivity of chemotherapy against drug-resistant cancer cells, Adv Mater 2012; 24:3831-3837.
[24] E. Lukianova-Hleb, et al. Improved cellular specificity of plasmonic nanobubbles versus nanoparticles in heterogeneous cell systems, PLoS One 2012; 7:e34537.
[25] D. Lapotko, E. Lukianova-Hleb, A. Oraevsky, Clusterization of nanoparticles during their interaction with living cells, Nanomedicine 2007; 2:241–253.